Product
Inhaled treprostinil
Aliases
Inhaled treprostinil solution
3 clinical trials
2 indications
Indication
Pulmonary HypertensionIndication
Chronic Obstructive Pulmonary DiseaseClinical trial
An Open-Label Extension Study of Inhaled Treprostinil in Patients With Pulmonary Hypertension Due to Chronic Obstructive Pulmonary Disease (PH-COPD)Status: Terminated, Estimated PCD: 2022-11-29
Clinical trial
TRIUMPH I: Double Blind Placebo Controlled Clinical Investigation Into the Efficacy and Tolerability of Inhaled Treprostinil Sodium in Patients With Severe Pulmonary Arterial HypertensionStatus: Completed, Estimated PCD: 2007-10-01
Clinical trial
A Phase 3, Randomized, Placebo-controlled, Double-blind, Adaptive Study to Evaluate the Safety and Efficacy of Inhaled Treprostinil in Patients With Pulmonary Hypertension Due to Chronic Obstructive Pulmonary Disease (PH-COPD)Status: Terminated, Estimated PCD: 2022-10-13